Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| LIGAND PHARMACEUTICALS INC | 51,172 | reported | 23 Sept 2024 | tx 114+501,923−173,283 |
| PALVELLA THERAPEUTICS, INC. | 44,123 | reported | 05 Feb 2026 | tx 4+340,155 |
| LIFECORE BIOMEDICAL, INC. \DE\ | 44,060 | reported | 15 Jul 2025 | tx 2+44,060 |
| RITTER PHARMACEUTICALS INC | 40,000 | reported | 11 Jul 2022 | tx 2+90,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 05 Feb 2026 | GRANT_AWARD | PALVELLA THERAPEUTICS, INC. | 44,123 | 0.00 USD | deriv |
| 15 Jul 2025 | GRANT_AWARD | LIFECORE BIOMEDICAL, INC. \DE\ | 19,506 | — | |
| 13 Dec 2024 | GRANT_AWARD | PALVELLA THERAPEUTICS, INC. | 167,100 | 0.00 USD | deriv |
| 23 Sept 2024 | EXERCISE | LIGAND PHARMACEUTICALS INC | 395 | 49.99 USD | |
| 23 Sept 2024 | EXERCISE | LIGAND PHARMACEUTICALS INC | 9,377 | 52.84 USD | |
| 23 Sept 2024 | SALE | LIGAND PHARMACEUTICALS INC | 201 | 102.05 USD | |
| 20 Sept 2024 | EXERCISE | LIGAND PHARMACEUTICALS INC | 4,982 | 49.99 USD | |
| 23 Sept 2024 | SALE | LIGAND PHARMACEUTICALS INC | 2,481 | 100.05 USD | |
| 23 Sept 2024 | SALE | LIGAND PHARMACEUTICALS INC | 7,090 | 101.61 USD | |
| 20 Sept 2024 | SALE | LIGAND PHARMACEUTICALS INC | 6,275 | 104.10 USD | |
| 20 Sept 2024 | EXERCISE | LIGAND PHARMACEUTICALS INC | 4,982 | 0.00 USD | deriv |
| 23 Sept 2024 | EXERCISE | LIGAND PHARMACEUTICALS INC | 395 | 0.00 USD | deriv |
| 23 Sept 2024 | EXERCISE | LIGAND PHARMACEUTICALS INC | 9,377 | 0.00 USD | deriv |
| 16 Sept 2024 | EXERCISE | LIGAND PHARMACEUTICALS INC | 849 | 58.49 USD | |
| 16 Sept 2024 | EXERCISE | LIGAND PHARMACEUTICALS INC | 914 | 55.75 USD | |
| 16 Sept 2024 | EXERCISE | LIGAND PHARMACEUTICALS INC | 3,340 | 60.94 USD | |
| 16 Sept 2024 | TAX_WITHHOLDING | LIGAND PHARMACEUTICALS INC | 319 | 105.00 USD | |
| 16 Sept 2024 | TAX_WITHHOLDING | LIGAND PHARMACEUTICALS INC | 1,938 | 105.00 USD | |
| 16 Sept 2024 | EXERCISE | LIGAND PHARMACEUTICALS INC | 671 | 49.99 USD | |
| 16 Sept 2024 | TAX_WITHHOLDING | LIGAND PHARMACEUTICALS INC | 472 | 105.00 USD | |
| 16 Sept 2024 | TAX_WITHHOLDING | LIGAND PHARMACEUTICALS INC | 485 | 105.00 USD | |
| 16 Sept 2024 | EXERCISE | LIGAND PHARMACEUTICALS INC | 3,340 | 0.00 USD | deriv |
| 16 Sept 2024 | EXERCISE | LIGAND PHARMACEUTICALS INC | 849 | 0.00 USD | deriv |
| 16 Sept 2024 | EXERCISE | LIGAND PHARMACEUTICALS INC | 671 | 0.00 USD | deriv |
| 16 Sept 2024 | EXERCISE | LIGAND PHARMACEUTICALS INC | 914 | 0.00 USD | deriv |